Lumedica Receives $1M Phase II NIH-SBIR Grant, in Support of Detecting Eye Disease Around the World.
DURHAM, NORTH CAROLINA - Lumedica Inc., a privately held company, [...]
Dr. Adam Wax Publishes Results of First Clinical Study of Low-Cost Retinal OCT
We've known since Lumedica's founding that the low-cost OCT would [...]
Retinal Division of Lumedica Awarded $250K in 2019 Luminate Accelerator Program
The Upstate New York economic development program, "Luminate," which helps [...]
New Approach to Skin Cancer Detection Driven by Affordable OCT
Dr. Fred Silver, Professor of Pathology at Robert Wood Johnson [...]
Lumedica Debuts Labscope 2.0
Lumedica launched its newest product at SPIE's BIOS / Photonics [...]
Dr. Adam Wax Talks Low-Cost OCT in BioPhotonics Magazine
Dr. Adam Wax makes the case for more widespread use [...]
Lumedica Lab Featured in Duke Magazine
Duke University has always celebrated both the academic and commercial [...]
OCT Used to Discover an Association Between Retinal Nerve Layer and Cognitive Decline
Are changes in the retinal nerve fiber layer (RNFL) associated [...]
Lumedica Advances to Semi-Finals in 2018 NC IDEA SEED Program
Durham, NC - Lumedica has made it to the semi-final [...]
Lumedica Partners With MD Innovation Tech Gmbh To Distribute Two New Products
Durham, NC - Lumedica, designers and manufacturers of OCT-based imaging [...]